These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22340094)

  • 21. Dynamic sequencing of circulating tumor DNA: novel noninvasive cancer biomarker.
    Lianos GD; Mangano A; Kouraklis G; Roukos DH
    Biomark Med; 2014; 8(5):629-32. PubMed ID: 25123031
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating nucleic acids as biomarkers in breast cancer.
    Schwarzenbach H
    Breast Cancer Res; 2013; 15(5):211. PubMed ID: 24090167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating methylated DNA.
    Herman JG
    Ann N Y Acad Sci; 2004 Jun; 1022():33-9. PubMed ID: 15251936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumour-derived predictive biomarkers in oncology.
    Hodgson DR; Wellings R; Orr MC; McCormack R; Malone M; Board RE; Cantarini MV
    Drug Discov Today; 2010 Feb; 15(3-4):98-101. PubMed ID: 20045486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A truth serum for cancer--microRNAs have major potential as cancer biomarkers.
    Chin LJ; Slack FJ
    Cell Res; 2008 Oct; 18(10):983-4. PubMed ID: 18833286
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
    Zen K; Zhang CY
    Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of circulating fetal nucleic acids: a review of methods and applications.
    Hung EC; Chiu RW; Lo YM
    J Clin Pathol; 2009 Apr; 62(4):308-13. PubMed ID: 19329710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.
    Lawrie CH; Gal S; Dunlop HM; Pushkaran B; Liggins AP; Pulford K; Banham AH; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS; Harris AL
    Br J Haematol; 2008 May; 141(5):672-5. PubMed ID: 18318758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer.
    Cho WC
    Expert Rev Mol Diagn; 2011 Nov; 11(8):763-6. PubMed ID: 22022936
    [No Abstract]   [Full Text] [Related]  

  • 30. Epigenetic and circulating biomarkers: future analytes for liquid biopsies.
    Razvi E
    Epigenomics; 2013 Dec; 5(6):615-7. PubMed ID: 24283876
    [No Abstract]   [Full Text] [Related]  

  • 31. A step forward in miRNA diagnostics: new and improved protocols for miRNA measurement.
    Miller S
    Bioanalysis; 2012 Jan; 4(2):121. PubMed ID: 22250794
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.
    Jung K; Fleischhacker M; Rabien A
    Clin Chim Acta; 2010 Nov; 411(21-22):1611-24. PubMed ID: 20688053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing cancer with a blood draw.
    Azvolinsky A
    J Natl Cancer Inst; 2012 Dec; 104(23):1774-5. PubMed ID: 23213181
    [No Abstract]   [Full Text] [Related]  

  • 34. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
    Bremnes RM; Sirera R; Camps C
    Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Biomarkers for Prediction of Treatment Response.
    Cappelletti V; Appierto V; Tiberio P; Fina E; Callari M; Daidone MG
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):60-3. PubMed ID: 26063889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological role of cell-free nucleic acids in cancer: the theory of genometastasis.
    García-Olmo DC; García-Olmo D
    Crit Rev Oncog; 2013; 18(1-2):153-61. PubMed ID: 23237557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicine. Keeping tabs on tumor DNA.
    Kaiser J
    Science; 2010 Feb; 327(5969):1074. PubMed ID: 20185705
    [No Abstract]   [Full Text] [Related]  

  • 38. RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.
    Silva J; Silva JM; García V; García JM; Domínguez G; Bonilla F
    Genes Chromosomes Cancer; 2002 Dec; 35(4):375-6. PubMed ID: 12378534
    [No Abstract]   [Full Text] [Related]  

  • 39. Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue.
    García-Olmo DC; Ruiz-Piqueras R; García-Olmo D
    Histol Histopathol; 2004 Apr; 19(2):575-83. PubMed ID: 15024717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer.
    Roth C; Kasimir-Bauer S; Pantel K; Schwarzenbach H
    Mol Oncol; 2011 Jun; 5(3):281-91. PubMed ID: 21398193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.